选择性雌激素受体调节剂雷洛昔芬的临床研究进展
被引量：2
摘要
选择性雌激素受体调节剂雷洛昔芬(raloxifene)在骨和心血管系统表现雌激素样作用,在乳腺和子宫表现抗雌激素样作用,并能预防乳腺癌的发生,目前临床上用于预防和治疗绝经后骨质疏松。结合近年文献,综述雷洛昔芬对绝经妇女的骨、心血管、乳腺、子宫方面的研究进展。
参考文献23
-
1Grese TA, Sluka JP, Bryant HU, et al. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci,1997,94:14105-14110. 被引量：1
-
2Kelly S, Nicole S, Jennifer M, et al. Raloxifene hydrochloride. Am J Health Syst Pharm,2000,57:1669-1678. 被引量：1
-
3Johnston CC Jr, Bjarnason NH, Cohen FJ, et al. Long-term effects of raloxifene on bone mineral density, bone turnover,and serum lipid levels in early postmenopausal women: three-year data from 2 doubleblind,randomized,placebo-controlled trials. Arch Intern Med,2000,160:3444-3450. 被引量：1
-
4Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene.JAMA, 1999,282:637-645. 被引量：1
-
5Sambrook PN, Geusens P, Ribot C, et al. Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International. J Intern Med,2004,255:503-511. 被引量：1
-
6Reid IR, Eastell R, Fogelman I, et al. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women. Arch Intern Med, 2004,164:871-879. 被引量：1
-
7Nickelsen T, Creatsas G, Rechberger T, et al. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. Climacteric,2001,4:320-331. 被引量：1
-
8Walsh BW, Kuller LH, Wild RA, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.JAMA, 1998,279:1445-1451. 被引量：1
-
9Walsh BW, Paul S, Wild RA, et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.J Clin Endocrinol Metab, 2000, 85:214-218. 被引量：1
-
10Mijatovic V, Netelenbos C, van der Mooren MJ, et al. Randomized,double-blind,placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women. Fertil Steril, 1998,70:1085 - 1089. 被引量：1
同被引文献44
-
1方维,廖清江.选择性雌激素受体调节剂类乳腺癌治疗新药的研究进展[J].药学进展,2004,28(6):247-252. 被引量：5
-
2李晓坤,徐芳.雌激素受体调节剂类药物的研究与开发[J].药学进展,2005,29(3):111-116. 被引量：2
-
3贵春山,沈建华,罗小民,朱维良,沈旭,蒋华良.雌激素受体和选择性雌激素受体调节剂的研究进展[J].中国药物化学杂志,2005,15(5):313-320. 被引量：16
-
4金丽,罗丽娜.游泳加中药淫羊藿综合疗法对去势大鼠骨代谢生化指标的作用[J].山东体育学院学报,2006,22(6):53-55. 被引量：7
-
5中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30 被引量：704
-
6Albright F,Smith PH,Rchardson AM.Postmenopausal osteoporosis:Its feature.JAMA.1941 ;116:2465-2476. 被引量：1
-
7Turner CH,Sato M,Bryant HU.Raloxifene preserves bone strength and bone mass in ovariectomized rats.Endocrinology.1994;135(5):2001-2005. 被引量：1
-
8Black LJ,Sato M,Rowley ER,et al.Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.J Clin Invest.1994;93(1):63-69. 被引量：1
-
9Hansdóttir H,Franzson L,Prestwood K,et al.The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.J Am Geriatr Soc.2004;52(5):779-783. 被引量：1
-
10Nakamura T,Liu JL,Morii H,et al.Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis.J Bone Miner Metab.2006;24(5):414-418. 被引量：1
二级引证文献4
-
1刘建宇,余根秀,魏星临.运动联合中药骨疏灵对去卵巢大鼠骨代谢的影响[J].中国老年学杂志,2013,33(22):5671-5673. 被引量：3
-
2张玲莉,陈炳霖,邹军.运动影响骨转换:促进或抑制骨细胞/破骨细胞的发育和活性[J].中国组织工程研究,2014,18(42):6838-6843. 被引量：16
-
3付蕾,柯丹丹,张玲莉,陆大江.运动与骨代谢:骨密度、骨生物力学及生化指标的评价[J].中国组织工程研究,2014,18(46):7487-7491. 被引量：19
-
4潘思京,郭海英,郑洁,赵依帆.运动对绝经后骨质疏松症影响的实验研究进展[J].海南医学,2015,26(1):86-89. 被引量：5
-
1张亚明,张元明.阿苯达唑致小儿38例不良反应文献分析[J].中国医院药学杂志,2007,27(11):1633-1634. 被引量：10
-
2张建良.110例药品不良反应报告分析[J].中国医药导报,2010,7(12):162-163.
-
3阿司匹林可预防乳腺癌[J].家庭医学（上半月）,2008(10):31-31.
-
4他莫昔芬维持治疗作为预防乳腺癌复发一线辅助治疗的建议遭拒绝[J].中华医学信息导报,2002,17(13):12-12.
-
5他莫昔芬能否预防乳腺癌尚有待于进一步研究[J].中华医学信息导报,2002,17(21):14-14.
-
6单海静.他莫昔芬预防乳腺癌的风险[J].药物不良反应杂志,2003,5(3):208-208.
-
7刘英鑫.他莫昔芬可预防乳腺癌[J].国外药讯,2003(6):23-23.
-
8万冬桂,李佩文,贾立群,蔡光荣.博宁预防乳腺癌骨转移疼痛的临床观察[J].中国肿瘤临床,2002,29(1):68-69. 被引量：5
-
9某些乳腺癌治疗药物有助预防乳腺癌[J].家庭用药,2013(7):7-7.
-
10盛平,黄文硕.头孢他啶致老年肾功能不全患者的中枢神经系统不良反应分析[J].中国实用医药,2007,2(6):46-47. 被引量：20
